Insider filing · UTHR
James Edgemond
CFO AND TREASURER
profile →
United Therapeutics Corporation
UTHR · Healthcare · 343 filings in 24 months
ticker →
James Edgemond sold $5.2M of United Therapeutics (UTHR)
Executed Jun 18, disclosed Jun 22, 4 days later.
Value, as filed
$5.2M
9,645 sh across 10 lots
Executed
Jun 18
the trade date, as filed
Disclosed
Jun 22
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JEJames Edgemond (CFO AND TREASURER) filed 34 Form 4 reports in the trailing twelve months (0 purchases, 34 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $10.0M of UTHR (20,840 sh across 6 lots, as filed), executed Dec 1 2025.
The name
UTHRHealthcare · United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by James Edgemond in UTHR
UTHRSALE
United Therapeutics Corporation
$4.6M8,586 sh across 7 lots
Exec Jun 22
Filed Jun 23 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.4M
9,760 sh across 11 lots
Exec Jun 15
Filed Jun 16 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.3M
9,666 sh across 6 lots
Exec Jun 11
Filed Jun 12 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.4M
9,920 sh across 7 lots
Exec Jun 8
Filed Jun 9 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.3M
9,760 sh across 8 lots
Exec Jun 4
Filed Jun 5 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.5M
10,000 sh across 9 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.7M
10,000 sh across 10 lots
Exec May 28
Filed May 29 · 5:30 PM ET UTHRSALE United Therapeutics Corporation $5.6M
9,840 sh across 13 lots
Exec May 26
Filed May 27 · 5:30 PM ET